SNORD5: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: SNORD5

NCBI ID: G692072

SNORD5

Other Name(s): Mgh28S-2410 | mgh28S-2410 | small nucleolar RNA, C/D box 5 | Small nucleolar RNA, C/D box 5

SNORD5: A Potential Drug Target Or Biomarker for Various Diseases

SNORD5 (Mgh28S-2410) is a protein that is expressed in various tissues of the human body, including the brain, heart, and blood vessels. It is a member of the Snor protein family, which is known for their role in cell signaling and division.

Recent studies have suggested that SNORD5 may be a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. This is because the Snor protein family has been shown to be involved in a wide range of cellular processes, including cell signaling, cell division, and inflammation.

One of the key features of SNORD5 is its role in the regulation of cell division. SNORD5 has been shown to play a role in the development and maintenance of neural stem cells, which are important for the development and maintenance of the nervous system. Additionally, SNORD5 has also been shown to play a role in the regulation of cell proliferation and differentiation, which are important for the growth and development of various tissues in the body.

Another potential drug target for SNORD5 is its role in the regulation of inflammation. SNORD5 has been shown to play a role in the regulation of immune responses and inflammation, which can make it a potential target for drugs that are used to treat autoimmune diseases or other inflammatory conditions.

In addition to its potential drug target properties, SNORD5 has also been shown to be a potential biomarker for a variety of diseases. For example, studies have shown that SNORD5 levels are often elevated in a variety of cancer tissues, which may make it a potential biomarker for cancer. Additionally, SNORD5 has also been shown to be elevated in the brains of individuals with neurodegenerative diseases, which may make it a potential biomarker for these conditions.

Overall, SNORD5 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in cellular processes and its potential as a drug or biomarker.

Protein Name: Small Nucleolar RNA, C/D Box 5

The "SNORD5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets